Useful for gene therapy by minimizing non-homologous end joining (NHEJ) derived Insertions or deletions (Indels)
Selective inhibition of Periostin variant (PN1) by monoclonal antibody
Excellent Vaccine Development/Research Platform
Achieved targeted large size gene knock-in animal production.
Cell Surface Antigen CD48 as A Novel Molecular Target for Antibody Therapy in Multiple Myeloma
Variant Specific Periostin Neutralization for Diabetic Retinopathy
Fragmentation of RANKL Eliminates Side-effect while Boosting Effect.
Investment / Co-development Opportunity for Start-up Company
About Bionauts.jp
